Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy

Spun out of the lab of former UCSF researcher Nicole Paulk, the biotech is targeting brain and eye tumors with a new kind of treatment it has dubbed “immuno-gene therapy.”